-
Spotlight on the Opioid Epidemic
Analysis Group’s Work in Tracking Impacts and Developing Responses
Abuse and misuse of opioids has reached “epidemic” proportions, according to numerous news reports, the US Department of Health and Human Services, the Centers for Disease Control, and the White House. Misuse of prescription opioids, such as oxycodone, hydrocodone, morphine, and methadone, has become a major focus of regulators, manufacturers, prescribers, and researchers. This issue of our Health Care Bulletin highlights some of the areas in which we believe our work is helping to make a difference: developing Suspicious Order Monitoring programs and tracking the impact of abuse-deterrent opioids – including the economic costs of abuse.
In this issue:
-
Health Care Bulletin
Making the Right Call: SOM for Prescription Opioids
As the opioid crisis continues, the Suspicious Order Monitoring (SOM) requirement has become an increasingly important enforcement tool.
-
Health Care Bulletin
Abuse-Deterrent Opioids and the Economic Costs of Abuse
How can industry participants help curb opioid abuse while maintaining appropriate access to care for patients?
-
Health Care Bulletin
Why Biosimilar Introduction May Be Different
Understanding the chain of impacts is critical to understanding the economic implications of biosimilar competition.
-
AG Feature
Causation in Product Liability: Taking a New Look
Proof of general causation can be an important precursor to establishing specific causation.
-
Health Care Bulletin
Patient-Reported Outcomes: Emerging Developments and Innovative Approaches
A summary of a recent ISPOR symposium examining new developments in the use of PRO measurements.
-
Health Care Bulletin
Biopharma Value-Based Pricing: How to Make It Work?
Value-based pricing/contracts have emerged as a way to deliver better health care, while reducing costs and financial risks.
-
AG Feature
Spotlight on Europe
Analysis Group’s experts in HEOR, epidemiology, pricing, reimbursement, and biostatistics make substantive contributions to decision making and product strategies in Europe.
-
Health Care Bulletin
A New Landscape for Comparative Effectiveness Research
A recent book includes perspectives from Analysis Group experts on the movement toward a more pragmatic application of real-world data.
-
Health Care Bulletin
Making More Precise Health Care Decisions with Machine Learning
The health care industry is a natural area for application of machine learning algorithms in CER.
-
Health Care Bulletin
Planting Trees to Reduce Health-Related Costs
Analysis Group’s research on the benefits of increased tree planting in urban areas quantifies the impact of lower particulate matter pollution on health-related costs.
Also on analysisgroup.com
-
Recent Health Care Events and News
-
In 2017, Analysis Group contributed to the following major conferences through sponsorships, poster presentations, and participation in symposia and on panels. Some of the conferences listed include links to more detailed summaries on the website. Click to view a full list of Analysis Group contributions to these conferences.
ISPOR 20th Annual European Congress
PROMIS® in Action: Clinical and Research Implementations and Implications
Academy of Managed Care Pharmacy (AMCP) Nexus 2017
PAINWeek 2017
33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)
Cambridge Healthtech Institute's Next Generation Dx Summit 2017
Alzheimer’s Association International Conference 2017
GCR Live IP & Antitrust California
ISPOR 22nd Annual International Meeting
2017 Pharma Industry Summit
4th Annual Business of Personalized Medicine Summit
AMCP Managed Care & Specialty Pharmacy Annual Meeting
Analysis Group Expert David Dranove Highlighted in Historic Health Care Merger ReviewIn what was widely considered to be the largest proposed merger ever in the health care industry, academic affiliate David Dranove of Northwestern University's Kellogg School of Management served as the expert economist for the US Department of Justice (DOJ) in its successful challenge of Anthem’s acquisition of Cigna.
-